pembrolizumab: Survival data Survival status and ctDNA levels for patients...

pembrolizumabR Documentation

Survival data Survival status and ctDNA levels for patients receiving pembrolizumab

Description

Survival data

Survival status and ctDNA levels for patients receiving pembrolizumab

Usage

data('pembrolizumab')

Format

A data frame with 94 rows and 15 variables:

id

Patient ID

age

Age at study entry

sex

Patient Sex

cohort

Study Cohort

l_size

Target lesion size at baseline

pdl1

PD L1 percent

tmb

log of TMB

baseline_ctdna

Baseline ctDNA

change_ctdna_group

Did ctDNA increase or decrease from baseline to cycle 3

orr

Objective Response

cbr

Clinical Beneficial Response

os_status

Overall survival status

os_time

Overall survival time in months

pfs_status

Progression free survival status

pfs_time

Progression free survival time in months

Source

https://www.nature.com/articles/s43018-020-0096-5


reportRmd documentation built on April 4, 2025, 2:03 a.m.